GQ1b-seronegative Fisher syndrome: Clinical features and new serological markers

Journal of Neurology

Volumn 259, Issue 7, 2012, Pages 1366-1374

  Koga, Michiaki ^a,b   Gilbert, Michel ^c   Takahashi, Masaki ^d   Li, Jianjun ^c   Hirata, Koichi ^b   Kanda, Takashi ^a   Yuki, Nobuhiro ^b,e  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anti GQ1b antibody; Campylobacter jejuni; Fisher syndrome; Ganglioside complex; Lipooligosaccharide

Indexed keywords

BIOLOGICAL MARKER; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GM1B; GANGLIOSIDE GQ 1B ANTIBODY; GANGLIOSIDE GT 1A; GANGLIOSIDE GT 1B; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BULBAR PARALYSIS; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FACIAL NERVE PARALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; MASS SPECTROMETRY; MYDRIASIS; OPHTHALMOPLEGIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSORY DYSFUNCTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES; BIOLOGICAL MARKERS; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MILLER FISHER SYNDROME; SEROLOGIC TESTS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84864282094     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6360-y     Document Type: Article

References (36)

1. Chiba A, Kusunoki S, Shimizu T, Kanazawa I (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Annu Neurol 31:677-679
2. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43:1911-1917 (Pubitemid 23318855)
3. Willison HJ, Veitch J (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 50:159-165
4. Ito M, Kuwabara S, Odaka S, Misawa S, Koga M, Hirata K et al (2008) Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 255:674-682
5. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain-Barré syndrome: relation to ant-ganglioside antibodies and Campylobacter jejuni infection in Japan. Annu Neurol 48:624-631
6. Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T (2003) Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 210:41-45 (Pubitemid 36539402)
7. Kaida K, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, HirakawaMet al (2006)Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 77:1043-1046 (Pubitemid 44338527)
8. Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K et al (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605-1611 (Pubitemid 40617699)
9. Nam Shin JE, Sckloo S, Mainkar AS, Monteiro MA, Pang H, Penner JL et al (1998) Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr Res 305:223-232 (Pubitemid 28164227)
10. Kimoto K, Koga M, Odaka M, Hirata K, Takahashi M, Li J et al (2006) Relationship of bacterial strains to clinical syndromes of Campylobacter- associated neuropathies. Neurology 67:1837-1843 (Pubitemid 44900763)
11. Godschalk PCR, Kuijf ML, Li J, St Michael F, Ang CW, Jacobs BC et al (2007) Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barré and Miller Fisher syndromes. Infect Immun 75:1245-1254 (Pubitemid 46385816)
12. Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S (1997) Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1a. J Neuroimmunol 74:30-34 (Pubitemid 27128974)
13. Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K et al (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain-Barré syndrome after Campylobacter jejuni enteritis. J Infect Dis 193:547-555 (Pubitemid 43202746)
14. Li J, Koga M, Brochu D, Yuki N, Chan K, Gilbert M (2005) Electrophoresis-assisted open-tubular liquid chromatography/ mass spectrometry for the analysis of lipooligosaccharide expressed by Campylobacter jejuni. Electrophoresis 26:3360-3368 (Pubitemid 43024498)
15. Parker CT, Gilbert M, Yuki N, Endtz HP, Mandrell RE (2008) Characterization of lipo-oligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations. J Bacteriol 190:5681-5689
16. Houliston RS, Vinogradov E, Dzieciatkowska M, Li J, St Michael F, Karwaski MF et al (2011) The lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosides. J Biol Chem 286:12361-12370
17. Houliston RS, Endtz HP, Yuki N, Li J, Jarrell HC, Koga M et al (2006) Identification of a sialate O-acetyltransferase from Campylobacter jejuni: demonstration of direct transfer to the C-9 position of terminal a-2, 8-linked sialic acid. J Biol Chem 281:11480-11486 (Pubitemid 43855403)
18. Dzieciatkowska M, Brochu D, van Belkum A, Heikema AP, Yuki N, Houliston RS et al (2007) Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni. Biochemistry 46:14704-14714 (Pubitemid 350276374)
19. Szymanski CM, St Michael F, Jarrell HC, Li J, Gilbert M, Larocque S et al (2003) Detection of conserved N-linked glycans and phase-variable lipooligosaccharides and capsules for Campylobacter cells by mass spectrometry and high resolution magic angle spinning NMR spectroscopy. J Biol Chem 278: 24509-24520 (Pubitemid 37548603)
20. St Michael F, Szymanski CM, Li J, Chan KH, Khieu NH, Larocque S et al (2002) The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168. Eur J Biochem 269:5119-5136 (Pubitemid 35345126)
21. Hitchcock PJ, Brown TM (1983) Morphological heterogeneity among Salmonella lopopolysaccharide chemotypes in silverstained polyacrylamide gels. J Bacteriol 154:269-277 (Pubitemid 13115445)
22. Odaka M, Yuki N, Hirata K (2001) Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 70:50-55 (Pubitemid 32096120)
23. Vincent A, Leite MI (2005) Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 18:519-525 (Pubitemid 41476137)
24. Hayashi Y, Koga M, Takahashi M, Uchida A, Yuki N (2001) Anti-GQ1b-negative case of overlapping Fisher's and Guillain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis. Rinsho Shinkeigaku 41:801-804 (in Japanese)
25. Tan H, Caner I, Deniz O, Büyükavci M (2003) Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G antibodies. Pediatr Neurol 29:349-350 (Pubitemid 37476241)
26. Gentilea S, Messinab M, Raineroa I, Lo Giudicea R, De Martinoa P, Pinessia L (2006) Miller Fisher syndrome associated with Burkitt's lymphoma. Eur J Neurol 13:423
27. Akinci G, Oztura I, Hiz-Kurul S (2010) Anti-GQ1b-negative Miller Fisher syndrome presented with one-sided horizontal gaze palsy. Turk J Pediart 52:317-320
28. Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S et al (2006) Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. J Neuroimmunol 177:201-208 (Pubitemid 44164342)
29. Koga M, Yoshino H, Morimatsu M, Yuki N (2003) Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 72:767-771
30. Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC et al (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131:1197-1208
31. Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K et al (2008) Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barré syndromes. J Neurol Neurosurg Psychiatry 79:1148-1152
32. Ilyas AA, Li SC, Chou DKH, Li YT, Jungalwala FB, Dalakas MC et al (1988) Gangliosides GM2, IV4GalNAcGM1b, and IV4Gal-NAcGD1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J Biol Chem 263:4369-4373
33. Yuki N, Taki T, Handa S (1996) Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 71:155-161 (Pubitemid 26413268)
34. Ortiz N, Rosa R, Gallardo E, Illa I, Tomas J, Aubry J et al (2001) IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. J Neuroimmunol 119:114-123 (Pubitemid 32781736)
35. Chikakiyo H, Kunishige M, Yoshino H, Asano A, Sumitomo Y, Endo I et al (2005) Delayed motor and sensory neuropathy in a patient with brainstem encephalitis. J Neurol Sci 234:105-108 (Pubitemid 40910350)
36. Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K (2004) Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies. J Neurol 251:24-29 (Pubitemid 38210486)